Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies (Q37953955)

25 August 2017

Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies (English)

1 reference

25 August 2017

0 references

0 references

Serene H John

1

1 reference

25 August 2017

John Kenneth

series ordinal

2

1 reference

25 August 2017

Archana S Gandhe

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

8 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

17

1 reference

25 August 2017

1

1 reference

25 August 2017

1-8

1 reference

The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis

25 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

FOXP3 gene expression in a tuberculosis case contact study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Changes in serum cytokine levels in active tuberculosis with treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Biomarkers of disease activity, cure, and relapse in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Characteristics and quality of randomized controlled trials in the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Novel tuberculosis vaccination strategies based on understanding the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Human gene expression profiles of susceptibility and resistance in tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

The quest for biomarkers in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta , and interleukin-4 mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Influence of Mycobacterium tuberculosis on differential activation of helper T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Immunological biomarkers of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Detection of interleukin-2 in addition to interferon-γ discriminates active tuberculosis patients, latently infected individuals, and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

Type 2 Cytokine Gene Activation and Its Relationship to Extent of Disease in Patients with Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2011.628048

10.3109/1354750X.2011.628048

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference